Ascorbic acid with glucose

General characteristics. Structure:

Active ingredients: 0,1 g of ascorbic acid, 0,877 g of a dextrose monohydrate.

Excipients (potato starch, stearic acid, calcium stearate).

Pharmacological properties:

Pharmacodynamics. Ascorbic acid plays an important role in regulation of oxidation-reduction processes, carbohydrate metabolism, coagulability of blood, an angenesis, promotes increase in body resistance. Ascorbic acid (vitamin C) is not formed in a human body, and arrives only with food. At the balanced and good nutrition of people has no deficiency in vitamin C.

Indications to use:

Prevention of a hypovitaminosis of Page. Ensuring the increased need of an organism for vitamin C in a growth period, pregnancies, breastfeeding, at high exercise and intellectual stresses, overfatigue, stressful states, during recovery after a long and serious illness.

Route of administration and doses:

Drug is accepted inside after food. Adult 50-100 mg/days; to children of 25 mg/days.

During pregnancy and a lactation on 300 mg/days within 10-15 days, then on 100 mg/days.

Features of use:

In connection with a promoting effect of ascorbic acid on formation of glucocorticosteroid hormones it is necessary to monitor function of adrenal glands and arterial pressure. Persons with deficit glyukozo-6-fosfatdegidrogenazy should use drug with care.

Side effects:

Allergic reactions to drug components are possible.

Interaction with other medicines:

Ascorbic acid increases absorption of drugs of group of penicillin, iron.

Contraindications:

Hypersensitivity to drug components. It is not necessary to appoint high doses the patient with the increased coagulability of blood, thrombophlebitises and tendency to fibrinferments, and also at the diabetes mellitus and states which are followed by the increased content of sugar in blood.

Overdose:

Symptoms: at prolonged use of high doses (more than 1 g) – a headache, increase in excitability TsNS, sleeplessness, nausea, vomiting, diarrhea, hyperacid gastritis, an ultseration of a mucous membrane of a GIT, oppression of function of the insulyarny device of a pancreas (a hyperglycemia, a glucosuria), a hyperoxaluria, a nephrolithiasis (from oxolat calcium), damage of the glomerular device of kidneys, a moderate pollakiuria (at reception of a dose more than 600 mg/days). Decrease in permeability of capillaries (deterioration in a trophicity of fabrics, increase in the ABP, hypercoagulation, development of mikroangiopatiya is possible).

Storage conditions:

To store in the dry, protected from light place at a temperature not above 25 °C. To store in the place, unavailable to children. A period of validity - 1 year. Not to use after a period of validity.

Issue conditions:

Without recipe

Packaging:

Tablets. On 10 tablets in planimetric bezjyacheykovy packaging from paper packaging with a polymeric covering or the printing aluminum foil varnished. On 10, 20, 30 tablets in a blister strip packaging from a film of the polyvinyl chloride and printing aluminum foil varnished or from paper packaging with a polymeric covering.

On 30, 40 tablets in banks from glass melt like BV, BDS, BS-T or polymeric. Each can or 1, 2, 3, 4, 5, 10 planimetric packagings together with the application instruction in a pack. On 300 planimetric bezjyacheykovy packagings with the equal number of application instructions in group packaging.